Kalaris Therapeutics Inc (KLRS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -13.35M | -9.32M | -11.33M | -14.88M | -7.44M | -4.33M | -3.97M | -4.52M | -4.14M | -34.48M | -27.12M | -32.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -79.41% | - | -161.91% | -274.84% | -64.59% | 87.45% | 85.36% | 85.92% | 86.9% | 1.85% | 6.08% | 30.89% |
| Net Income | -10.86M | -10M | -11.89M | -11.35M | -10.2M | -38.08M | -5.65M | -3.41M | -3.47M | -44.27M | -45.27M | -41.18M |
| Depreciation & Amortization | 10K | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.64M | 0 | 547K |
| Stock-Based Compensation | 0 | 0 | 638K | 0 | 374K | 262K | 322K | 31K | 31K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.37M | -2.2M | -68K | -1.75M | 35K | 32.31M | 1.53M | 931K | 105K | 9.23M | 9.62M | 9.3M |
| Working Capital Changes | -1.14M | 2.87M | -9K | -1.78M | 2.35M | 1.19M | -172K | -2.08M | -801K | -3.08M | 8.52M | -782K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 43K | 0 | 0 | 0 | -128K | 138K | -87K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -376K | 874K | -3.2M | 1.31M | 934K | 1.7M | -597K | -1.24M | 508K | -1.86M | 5.39M | -486K |
| Cash from Investing | -50.35M | 14.98M | -34.71M | 0 | 0 | 0 | 0 | 0 | 0 | -66.85M | 37.89M | 41.72M |
| Capital Expenditures | 0 | -17K | -183K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 74K | 50M | 0 | 2.35M | 107.27M | 1K | 4.98M | 6.58M | 6.86M | 0 | 70.48M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 7.5M | 7.5M | 0 | 5M | 4.99M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 74K | 50M | 0 | 0 | 0 | 1K | 0 | 1.59M | 6.74M | 0 | 70.48M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -5.15M | 99.77M | 0 | -17K | -5K | 117K | 0 | 0 | 0 |
| Net Change in Cash | -63.63M | 55.67M | -46.04M | -12.54M | 99.83M | 12.12M | 1.01M | 2.06M | 2.72M | -101.33M | 81.26M | 9.61M |
| Free Cash Flow | -13.35M | -9.33M | -11.52M | -14.88M | -7.44M | -4.33M | -3.97M | -4.52M | -4.14M | -34.48M | -27.12M | -32.12M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -79.41% | - | -166.14% | -274.84% | -64.59% | 87.45% | 85.36% | 85.92% | 86.9% | 1.85% | 6.08% | 30.89% |
| FCF per Share | -0.56 | -0.41 | -0.62 | -0.80 | -1.84 | -0.87 | -0.80 | -0.91 | -0.83 | -6.96 | -6.59 | -7.92 |
| FCF Conversion (FCF/Net Income) | 1.23x | 0.93x | 0.95x | 1.31x | 0.73x | 0.11x | 0.70x | 1.33x | 1.19x | 0.78x | 0.60x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |